Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. - Wikidata - awgldk - TriplyDB

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.

http://www.wikidata.org/entity/Q37855173

about

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature Population and Functional Genomics of Neisseria Revealed with Gene-by-Gene Approaches Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge High-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2 The Neisseria gonorrhoeae Obg protein is an essential ribosome-associated GTPase and a potential drug target Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012 First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009-2013.Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin.Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.Sexually transmitted diseases treatment guidelines, 2015.Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013 Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology Gonorrhea infection in women: prevalence, effects, screening, and management.Exploring the Benefits of Molecular Testing for Gonorrhoea Antibiotic Resistance Surveillance in Remote Settings Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.Sexually transmitted disease (STD) update: a review of the CDC 2010 STD treatment guidelines and epidemiologic trends of common STDs in Hawai'i.Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya.In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatm High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Management of gonococcal infection among adults and youth: New key recommendations.Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.Gonococcal resistance: are cephalosporins next?Moving forward in tackling antimicrobial resistance: WHO actions.Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?

P2860

Q24633203-91ED2149-581E-4E45-A44A-20DC4FCECD40 Q26745785-E7329F99-D75D-4BAA-B8CD-3ACF1AB912D3 Q26751426-84CB2C90-3FDA-4631-B166-E3F85F97A93C Q26796265-2BDE67D7-780F-4102-A384-08AAA414B348 Q28484022-C3347C12-6DAD-42E7-9C07-52C7FE5A29AA Q28485125-E1C2EB2D-1EF6-48EF-84CA-DD3920D150EC Q30724177-90DF596C-65E3-4CDD-9362-8052B6D2A50A Q30865577-206D38C7-9A11-4D6B-BCEE-AABF867BCF20 Q32383726-C1CC8843-55DB-47C2-9C0B-D27FECA53D3E Q33822930-3182E5C0-56CD-476C-8E11-ECF785849BDA Q33836057-A9D27731-6F0F-4C67-A1EC-C68FC4594961 Q34057315-D3F9534F-7BE0-4081-9CAC-8F222CDAD147 Q34123726-9871EF4C-8CF1-46E6-97B6-7A5E56ABF562 Q34126619-B3C10B85-9339-410A-AF56-1244A425C1CB Q34479272-19756C5F-A347-4138-B984-21CAAB3A02BC Q34529360-77FE8A70-2EEE-4A91-9895-CFC1F02FEFBE Q34563908-DBDD3F7B-9CC3-49EC-A862-2513B36E8435 Q34627129-788996EE-1301-4AAC-A393-5467BED9BECC Q34632863-423E10F9-180C-4732-BA04-35E86121C988 Q34677116-6960E688-17F3-4DFE-9A07-E3F9D95A5D58 Q35047954-7DD809F8-23E6-49D6-8F6C-C5FBC6296FB6 Q35087427-E9EEAC5D-B1B5-4285-9F79-A2AEBA51C437 Q35090128-1B291261-2D17-413C-8379-EFB2CFD99536 Q35147305-61CAEE18-0EBE-4FFB-BA6A-7214AE674D6E Q35693328-FE10BD75-BE51-4852-844D-6E47A25E2AD7 Q35848139-0DB381C0-5C00-4130-A2E5-422FFA5D80D3 Q35856141-8BEF0923-8427-4F82-BE5B-72387503C379 Q35893523-2C465921-F6BF-4B4B-BF26-4708825EEBAC Q35941481-A981B9E2-C62D-4116-88CB-95CDAE268A58 Q35961007-06B2F245-D22F-4883-9F4D-AF2B8A1A4DB2 Q36086360-07445A5A-0E9D-4A1C-86A9-3387501BB363 Q36166278-2085F6B0-78E9-4D65-9B63-98924305471F Q36439155-81D82FF4-D531-487D-98A4-F2325BFCC6D5 Q36558447-4F35B47B-C536-43DB-AFA0-6AA5BDD97500 Q37263477-37E859C0-CCF4-4CCE-A2C6-378C33A2B9CA Q37539227-C03D7167-4ECF-4E0E-83AB-1401B2C63D88 Q37593105-99570E0D-EFCA-4953-B8E6-BFE01B48845D Q37848735-17FF8A4C-E8C9-4788-80D3-AD80F51923A5 Q38160730-42FD3853-188F-49F3-B158-3F3BFEDF25FE Q38441669-A27D90B3-7A89-44A7-B1C9-4745D109FC68

P2860

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.

http://www.wikidata.org/entity/Q37855173

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Two cases of failed ceftriaxon ...... cular microbiological methods.

@en

Two cases of failed ceftriaxon ...... cular microbiological methods.

@nl

type

label

Two cases of failed ceftriaxon ...... cular microbiological methods.

@en

Two cases of failed ceftriaxon ...... cular microbiological methods.

@nl

prefLabel

Two cases of failed ceftriaxon ...... cular microbiological methods.

@en

Two cases of failed ceftriaxon ...... cular microbiological methods.

@nl

P1433

Q37855173-98583D8D-F711-4823-89D2-556F3651706B

P1476

Q37855173-2988B387-16EF-43B9-B9E8-39A56680044E

P2093

Q37855173-18C034A5-C087-4197-923F-B0CB228A05F8

Q37855173-2421A407-8972-4023-982B-FB0DABC0BCEE

Q37855173-50284AEB-006D-4ECC-8E79-3DDF9398C030

Q37855173-8C633DC5-F226-42A1-8BC7-27297966935B

Q37855173-9C6ED105-3706-4789-9621-D25D5A8C8CA1

Q37855173-BFE1C35F-6F76-447B-800C-7D56A24C115D

Q37855173-CC030B13-829B-41C6-A45F-035BBD696B6C

P304

Q37855173-1ABF3D2C-6F3E-442C-80D7-30C3A09AC029

P31

Q37855173-E1FAE8C7-D0C6-4470-984E-17D35BC48E19

P356

Q37855173-EDDA9290-7E02-4355-AF17-4728A97A619E

P433

Q37855173-06C34226-3970-40D6-B903-446563C8E9EA

P478

Q37855173-BD589491-12A5-40A7-ACB2-096BB1A93104

P50

Q37855173-8735B5C0-8D93-43BE-8D3C-847F7789E8F8

P577

Q37855173-9987B6E8-B3B6-47C0-A8A5-28E10CE13715

P5875

Q37855173-9B0BE73E-9E90-41BB-9FB2-FEC22CD2BD9F

P698

Q37855173-8D530D1D-809F-49CE-BF7A-460BB01885F2

P356

P1433

Journal of Medical Microbiology

P1476

Two cases of failed ceftriaxon ...... cular microbiological methods.

@en

P2093

Athena Limnios

http://www.w3.org/2001/XMLSchema#string

Christopher Bourne

http://www.w3.org/2001/XMLSchema#string

Christopher Carmody

http://www.w3.org/2001/XMLSchema#string

John Tapsall

http://www.w3.org/2001/XMLSchema#string

Phillip Read

http://www.w3.org/2001/XMLSchema#string

Sanghamitra Ray

http://www.w3.org/2001/XMLSchema#string

Theo Sloots

http://www.w3.org/2001/XMLSchema#string

P304

683-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1099/JMM.0.007641-0

http://www.w3.org/2001/XMLSchema#string

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24280595

http://www.w3.org/2001/XMLSchema#string

P698

19369534

http://www.w3.org/2001/XMLSchema#string